Form 4: GeneDx Holdings CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
GeneDx Holdings CEO Katherine Stueland sold 2,618 shares of Class A Common Stock on March 12, 2024, to cover tax withholding obligations related to the vesting and settlement of restricted stock units.
Summary
- Katherine Stueland, CEO of GeneDx Holdings Corp., sold 2,618 shares of Class A Common Stock on March 12, 2024.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- The shares were sold at a weighted average price of $9.2097, with individual transactions ranging from $9.08 to $9.21.
- Following the transaction, Stueland directly owns 56,507 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| 03/12/2024 | Date of stock sale transaction. |
| 03/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.